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Recombinant produced human tumour necrosis factor (TNF) has been studied to characterise the subunit 
structure of the protein. TNF is shown to be a trimer M, 52000 in which the subunits are associated in 
a compact, triangular form. In secondary structure it belongs to the all-/I class of proteins. It has high ther- 
modynamic stability and the unfolded subunits can fold and associate spontaneously to form native, biolog- 
ically active TNF. 
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1. INTRODUCTION 
Tumour necrosis factor can be produced in 
serum by treatment with lipopolysaccharide of an 
animal previously primed with materials such as 
BCG or zymosan [l]. Its ability to bring about 
regression of tumours in mice makes this protein a 
focus of attention. Human TNF has been express- 
ed in E. coli from genetic material derived from 
cell lines [2,3] and this has opened the door to 
characterisation of structure-function relation- 
ships. We have clarified the uncertainty in the 
literature concerning the polymeric nature of the 
smallest form of TNF present at concentrations as 
low as 50 ng -ml-’ and investigated its conforma- 
tion and assembly. 
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Abbreviutions: TNF, tumour necrosis factor; Gdn . HCl, 
guanidine HCl; SDS-PAGE, polyacrylamide gel elec- 
trophoresis in the presence of SDS; AG’H,o, apparent 
free energy of stabilization in the absence of denaturant; 
CD, circular dichroism; UV, ultraviolet 
2. MATERIALS AND METHODS 
Chemicals were analar grade (BDH, Poole, 
England). Tris was from Sigma and Ultrapure 
GdneHCI from BRL. The buffer used in the ex- 
periments was 0.01 M Tris, 0.09 M NaCI, 1 mM 
disodium EDTA, adjusted to pH 8.5 with HCl 
unless otherwise described in the text. 
Recombinant TNF was supplied by Biogen Res. 
Corp. (Cambridge, USA). It was assayed as 
described [3]. 
2.1. Circular dichroism 
Circular dichroism spectra were measured using 
a Jobin-Yvon dichrograph IV linked to a BBC 
microcomputer for recording data. Spectra are 
averages of 4-10 scans with the baseline sub- 
tracted. Protein concentrations were estimated us- 
ing a calculated value of A:& = 12.7 at 278 nm. 
All solutions were filtered (0.22 pm, Millipore 
GVWP filters) before use. 
Additions of Gdn . HCl were made from a con- 
centrated stock solution. The equilibrium un- 
folding data were analysed using the linear 
extrapolation method [4]. A plot of lnKes versus 
[Gdn - HCl] was extrapolated to [Gdn - HCI] = 0 to 
obtain a value of the apparent free energy change 
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for the transition at zero concentration of 
denaturant, AC&O. lti& was plotted against 
ln[Gdn. HCI] to obtain Cm, the midpoint of the 
transition where I&, = 0 and the slope, n, which 
is a measure of the cooperativity of the transition. 
Unfolding and refolding kinetics were measured 
as described in the legends. 
2.2. Absorbance 
Absorbance spectra and protein concentrations 
were measured using a Cary 210 spec- 
trophotometer with thermostatted cell holders. 
2.3. Fluorescence -4 
Fluorescence measurements were made using a 
Perkin Elmer MPF3 spectrofluorimeter with ther- 
mostatted cell holder. All solutions were filtered 
(0.22 pm, Millipore) before use. 
2.4. Analytical ultracentrifugation 
Sedimentation equilibrium and sedimentation 
velocity measurements were made as described [5]. 
2 5. Urea-gradient polyacrylamide gel 
electrophoresis 
Urea-gradient polyacrylamide gel elec- 
trophoresis was carried out in a BRL model V-16-2 
vertical gel electrophoresis apparatus using 19.5 x 
16.0 cm gel plates with 1.5 mm thick spacers. The 
electrophoresis buffer was 50 mM Tris-glycine, pH 
9.2. Preparation of the urea gradient (O-8 M) and 
acrylamide gradient (15-l 1%) and conditions of 
polymerization were carried out according to 
Goldenberg and Creighton [6]. 
Fig.1. Sedimentation equilibrium of recombinant 
human TNF. The logarithm of absorbance at 280 nm 
(InA& is plotted as a function of the square of the 
distance in cm from the axis of rotation (3). The slopes 
were evaluated from the least squares fit of the data. 
Plots were derived from TNF in 50 mM Tris-HCl, pH 
7.5, 1% (w/v) KC1 at starting concentrations of 0.125 
(x) and 0.48 (0) mg *ml-‘, respectively. Sedimentation 
equilibrium was established by centrifugation at 
molecular mass of the murine TNF was similarly 
shown to be 50 kDa. These results show that TNF 
is a trimer held together by non-covalent in- 
teractions. 
3. RESULTS AND DISCUSSION 
3.1. Molecular structure of TNF 
The relative molecular mass of human TNF as 
measured by SDS-PAGE in the absence or 
presence of reducing agent was shown to be 
17 kDa in keeping with the DNA-derived sequence 
value of 17356 Da [3]. Molecular masses measured 
by sedimentation equilibrium at starting protein 
concentrations of 0.125 mgeml-’ and 0.48 mg. 
ml-’ were 49.6 and 50.4 kDa, respectively. The 
linearity of the plots of protein distribution (fig. 1) 
over a total range of 0.02-0.8 mg *ml-’ show that 
there is no dissociation or further association of 
TNF over this range of concentration. The 
The mode of association of the subunits will 
determine the flow properties of the trimer in solu- 
tion, the two extreme configurations being a linear 
and a planar, triangular association, respectively. 
Experimental values of the geometric factor for 
subunit arrangement were calculated from the 
hydrodynamic properties of TNF (table 1) by the 
method of Teller et al. [7] and compared with 
predicted values. These results lead to the proposal 
that TNF is associated with two inter subunit con- 
tacts for each subunit. 
The near UV CD spectrum of TNF (fig.2a) ex- 
hibits an intense positive ellipticity with a double 
peak at 280.5 and 285.5 nm and a minor peak at 
292.5 nm. These reflect the asymmetric environ- 
ment of one or both of the two tryptophan residues 
together with a contribution from tyrosine 
residues. The CD spectrum in the range 
180 
46 47 48 49 50 51 
R* (CM*) 
14000 rpm for 18 h at 20°C. 
Volume 211, number 2 FEBS LETTERS January 1987 
110 Table 1 
Hydrodynamic properties of recombinant human TNF 
70 
7 = 60 
._ 
i, 
“5 
*JO 
-0 
kz 
30 
20 
10 
0 
Parameter Value 
v (ml-g-‘) 0.729 
so 4.13 s 
f, cm x lOa (a) 3.01 
r, cm x lOa (b) 2.70 
r, cm x 10’ (c) 2.47 (2.81) 
f/f (4 1.22 (1.07) 
Fn (e) 0.967 (0.956, 0.864) 
(a) Stokes’ radius estimated from iW, of 52000, ~20,~ of
4.13 S and v of 0.729 mlag-’ according to the Svedberg 
equation (181. (b) Stokes’ radius estimated from gel 
permeation chromatography on LKB Ultrogel AcA54. 
(c) Stokes’ radius predicted for an anhydrous sphere or 
a hydrated sphere (value in parentheses) of Mr of 52000 
and v = 0.729 rnlng-‘. A hydration value of 0.350 g 
HzO/g protein was calculated from the amino acid 
composition [ 191. (d) Frictional coefficient calculated 
using fo values calculated for an anhydrous sphere or a 
hydrated sphere (value in parentheses). (e) Geometric 
factor for subunit arrangement calculated according to 
the method of Teller et al. [7]. The values in parentheses 
are the predicted values for a planar triangular trimer 
250 270 290 310 
WAVELENGTH (nm) 
and a linear trimer, respectively 
a- 
tbl 
6. 
-6 - 
-12 A 
200 210 220 230 240 250 
WAVELENGTH (nml 
200-250 nm (fig.2b) is of relatively low intensity 
with a trough centred at 221 nm. Analysis of the 
spectrum in terms of secondary structure [8] gives 
3% helix and 45% @-structure placing TNF, like 
interleukin 1 [9], in the all-fi class of proteins [lo]. 
Human TNF contains two cysteine residues 
which form a disulphide bond as shown by reac- 
tion with 2-nitro-5-thiobenzoic acid [ 111. This 
bond can readily be cleaved under non-denaturing 
conditions and the resultant sulphydryl groups 
alkylated with iodoacetamide. The product has M, 
= 50600, ~20.~ = 4.0 S and biological activity 
similar to that of native TNF. The disulphide does 
Fig.2. Circular dichroism spectra of TNF. The spectra 
are an average of 4 (near UV) and 8 (far UV) scans with 
the baseline subtracted. Protein concentration 
0.87 mg/ml in 0.01 M Tris, 0.09 M NaCI, 1 mM 
disodium EDTA, pH 8.5. Spectra were recorded at 20°C 
using 1 cm and 0.01 cm pathlength cells at 1 nm and 
2 nm bandwidths for near and far UV regions, 
respectively. The far UV spectrum is shown for native 
TNF (N) and for TNF unfolded (U) in 4 M Gdm. HCl. 
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not therefore appear to play an important role in 
stability of subunit association or activity. 
On urea-gradient ele~rophoresis, TNF shows a 
single transition between 0 and 8 M urea which oc- 
curs at -3.8 M urea at pH 9 and 8°C. The transi- 
tion is continuous and independent of whether 
TNF is applied in zero or 8 M urea (fig.3). Under 
these conditions therefore TNF unfolds reversibly 
and rapidly relative to the time of electrophoresis. 
The thermodynamic stability was estimated 1121 
under these conditions as being 26 kJ - mol-‘. 
Initial attempts to study the unfolding equilibria 
in free solution showed that at 25°C unfolded TNF 
in 5 M Gdn - HCl aggregates ignificantly so that 
refolding after 60 s in that solvent results in only 
50-~~0 yield of native protein. Yields of 80-90~0 
can be obtained however when TNF is unfolded in 
high concentrations of Gdn. HCl at 6°C over the 
pH range 5.9-9.5. Samples which refolded at pH 
8.5 were active on bioassay. The reversible un- 
folding transitions at pH 8.5 (fig.4) measured by 
near and far UV ellipticity at 11°C are superim- 
posable. This fact and the high cooperativity (n = 
dln K’/dln[Gdn.HCl] = 17.6) support the 
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Fig.3. Urea-gradient electrophoresis of recombinant 
human TNF. The buffer for electrophoresis and sample 
application was 50 mM Tris-glycine, pH 9.2. 
Electrophoresis was towards the anode at 6.5 V-cm-’ 
for I5 h at 8°C. (A) Native TNF (15Opg) and (B) native 
TNF (150 cg) migrated into the gel before application of 
unfolded TNF (15Opg) dissolved in 8 M llr~= 
FN fX1 
[Gdn. HCll mot/l 
Fig.4. Reversible unfolding transition for TNF. The 
unfolding and refolding were monitored by ellipticity at 
285.5 nm (a), 292.5 nm (A) and 208 nm (solid line). 
Protein solutions in 0.01 M Tris, 0.09 M NaCI, 1 mM 
disodium EDTA, pH 8.5, were titrated with small 
weighed additions of a concentrated stock solution of 
Gdn. HCI made up in the same buffer to give final 
protein concentrations of 0.34-0.82 mg/ml. 
assumption of a 2-state transition and strong in- 
teraction of the subunits. The thermodynamic 
stability of the native protein relative to the fully 
unfolded state is 40.6 + 3.6 kJ .mol-’ based on 
results from both near and far UV CD. The mid- 
point of the transition under these conditions oc- 
curs at C, = 1.14 M Gdn . HCI. 
This transition was further characterised by 
sedimentation experiments carried out under the 
same conditions. At zero and 0.5 M Gdn * HCl 
sedimentation coefficients were 4.0 S and 3.8 S, 
respectively, and at 4 M Gdn. HCl, ~20,~ = 1.0 S. 
At intermediate concentrations within the transi- 
tion high s values were obtained indicating ag- 
gregation. Similar experiments carried out in urea 
solutions showed similar phenomena, with a tran- 
sition occurring between 4 and 5 M urea. Sedimen- 
tation equilibrium in 6 M urea led to a convex plot 
of lnc vs 4 indicating non-ide~ity. The estimated 
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value of M, = 16000 was obtained using a partial 
specific volume v = 0.712 mleg-’ [13]. 
These results show that the single denaturation 
transition is between folded trimer and unfolded 
monomer with no intermediate species other than 
artifactual aggregates. The trimer is stable over a 
wide pH range, there being no change in sedimen- 
tation coefficient between pH 4.8 and 10.5. 
Measurements of fluorescence show that TNF is 
denatured on lowering the pH with a pK of ap- 
prox. 4.3 leading to a product shown by sedimen- 
tation experiments to be moderately aggregated. 
This is consistent with the irreversible loss of TNF 
found on dialysis for 24 h at pH values below 5.5 
1141. 
The strength of the interaction between the 
monomers is supported by a gel filtration experi- 
ment in which TNF was radiolabelled during 
biosynthesis. At an initial concentration of 
200 ng - ml-’ this eluted at a volume identical to 
that for unlabelled TNF at higher concentrations 
(7 mg -ml-‘) showing that no dissociation of the 
trimer could be detected at the lower concen- 
tration. 
3.3. Conclusions 
There is a species variation in the extent of TNF 
glycosylation, for example, murine TNF appears 
in nature to be a glycoprotein [14] whereas there is 
no evidence for the glycosylation of human TNF. 
Both human and murine recombinant TNF have 
been shown to be trimers so that glycosylation does 
not appear to affect the degree of polymerisation. 
The recombinant protein studied here has identical 
chemical composition to authentic human TNF 
and therefore reflects properties of the authentic 
molecules. Existing uncertainties concerning the 
subunit structure, e.g. [15], have been resolved by 
the determination of an absolute molecular mass 
using equilibrium sedimentation which shows 
beyond doubt that TNF is a trimer of 17 kDa 
polypeptides. The significance of higher molecular 
mass species with TNF activity, e.g. [16], has yet to 
be clarified. The subunits are associated strongly in 
a compact form, showing no sign of dissociation at 
low concentrations. The bioassay however is car- 
ried out in the picogram concentration range, 
probably similar to levels in serum, so it has yet to 
be established conclusively whether the monomer 
or the trimer is active. However, the local concen- 
tration of the protein at the region of the cell sur- 
face receptor in vivo may be significantly higher 
than the normal serum levels. The demonstrated 
strong tendency to associate would be important if 
the TNF receptor is activated by being cross linked 
by the ligand, as proposed for the IgE stimulation 
of mast cells [17] and for stimulation of the 
primary immune response [ 181. 
The protein, which is of the all@ type, can be 
dissociated into fully unfolded subunits and will 
then refold spontaneously into the active, native 
conformation. The 17 kDa polypeptide thus con- 
tains the information required for folding to the 
species which associates specifically to give 
biologically active TNF. This shows that the 
unusually long 76 residue presequence is not re- 
quired for folding as in proinsulin [19] or pep- 
sinogen [20] but is conformationally independent 
and presumably therefore has a separate 
biochemical function in secretion or targetting. 
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